Claro Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Claro Advisors's MRNA Position: Q3 2026 in Review
Claro Advisors opened a new position in Moderna (MRNA) in Q3 2026: 1,340 shares worth $258K. The stake represents 0.03% of the portfolio and ranks #441 among its holdings. This is a return to the name: Claro Advisors previously reported a position in MRNA as recently as Q4 2024.
Claro Advisors first reported a position in MRNA in Q3 2020 and has held it in 19 quarters since. The position peaked at $960K in Q3 2021. 1,049 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Claro Advisors held 1,340 shares of Moderna worth $258K as of Q3 2026.
- Moderna was a new Claro Advisors position in Q3 2026.
- Moderna made up 0.03% of Claro Advisors's portfolio in Q3 2026, its #441 holding.
- Claro Advisors first reported a position in Moderna in Q3 2020 and has held it in 19 quarters since.
- Claro Advisors's Moderna position peaked at $960K in Q3 2021.
- 1,049 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Claro Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.